Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01721772 |
|---|---|
| Brief Title: | Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma (CheckMate 066) |
| First Submitted : | November 2, 2012 |
| First Submitted that Met QC Criteria : | November 2, 2012 |
| First Posted : | November 6, 2012 (Estimate) |
| Results First Submitted : | November 20, 2015 |
| Results First Submitted that Met QC Criteria : | January 27, 2016 |
| Results First Posted : | February 25, 2016 (Estimate) |
| Certification/Extension First Submitted : | July 3, 2015 |
| Certification/Extension First Submitted that Met QC Criteria : | July 3, 2015 |
| Certification/Extension First Posted : | July 28, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 17, 2022 |
| Last Update Posted : | July 12, 2022 |